TrademarkOpen
Search / US trademark / 99104560
US trademark

DIFFLAM

Allowed — statement of use stage
First Extension - Granted

Status timeline

  1. 26 Mar 2025
    Application filed
    New Application Entered
  2. 25 Aug 2025
    Assigned to an examining attorney
    Assigned To Examiner
  3. 25 Aug 2025
    Approved for publication
    Approved For Pub - Principal Register
  4. 23 Sep 2025
    Published for opposition
    Published For Opposition
  5. 18 Nov 2025
    Notice of allowance issued — statement of use required
    Noa E-Mailed - Sou Required From Applicant
  6. 4 May 2026
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
All 13 USPTO events
2026-05-05Notice Of Approval Of Extension Request E-Mailed
2026-05-04Sou Teas Extension Received
2026-05-04Sou Extension 1 Filed
2026-05-04Sou Extension 1 Granted
2025-11-18Noa E-Mailed - Sou Required From Applicant
2025-09-23Published For Opposition
2025-09-23Official Gazette Publication Confirmation E-Mailed
2025-09-17Notification Of Notice Of Publication E-Mailed
2025-08-25Assigned To Examiner
2025-08-25Approved For Pub - Principal Register
2025-03-26New Application Entered
2025-03-26New Application Office Supplied Data Entered
2025-03-26Application Filing Receipt Mailed

Goods & services

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for the relief and treatment of cold, cough, flu, sore throats, inflammation, aphthous ulcer, ulceration; Medicated mouth washes; Cough lozenges; Throat lozenges; Medicated lozenges; Drug delivery agents in the form of lozenges that facilitate the delivery of pharmaceutical preparations; Cough pastilles for medical use; Medicated throat sprays; Gargles; Medicated oral care gels

Source & freshness

Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 6 May 2026; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.